Search for Clinical Trial Results
Mesothelioma - 58 Studies Found
Status | Study |
Terminated |
Study Name: Antineoplaston Therapy in Treating Patients With Advanced Mesothelioma Condition: Malignant Mesothelioma Date: 1999-11-01 Interventions:
|
Completed |
Study Name: Pemetrexed, Cisplatin, and Vitamin B12 in Treating Patients With Mesothelioma of the Chest That Cannot Be Removed by Surgery Condition: Malignant Mesothelioma Date: 2007-10-05 Interventions:
|
Completed |
Study Name: Liposomal-Cisplatin Analogue (L-NDDP) in Treating Patients With Malignant Pleural Mesothelioma Condition: Malignant Mesothelioma Date: 1999-12-10 Interventions:
|
Completed |
Study Name: Active Symptom Control With or Without Chemotherapy in Treating Patients With Malignant Pleural Mesothelioma Condition: Malignant Mesothelioma Date: 2004-01-09 Interventions:
|
Completed |
Study Name: ONCONASE Plus Doxorubicin Versus Doxorubicin Alone For Patients With Malignant Pleural or Peritoneal Mesothelioma Who Have Had No More Than One Prior Chemotherapy Regimen Condition: Malignant Mesothelioma Date: 1999-11-01 Interventions:
|
Completed |
Study Name: Tomotherapy Treatment for Mesothelioma Condition: Mesothelioma Date: 2007-05-02 Interventions: Procedure: Tomotherapy 40 Gy in 15 fractions, at one fraction per day. Dose will be prescribed to the 95 |
Completed |
Study Name: Eloxatin® Plus Gemcitabine Chemotherapy for Mesothelioma Condition: Mesothelioma Date: 2009-03-09 Interventions: Drug: Oxaliplatin/Gemcitabine Gemcitabine 1000mg/m2 IV infusion for 90 minutes followed by oxaliplatin 1 |
Recruiting |
Study Name: A Phase 2 Study of Durvalumab in Combination With Tremelimumab in Malignant Pleural Mesothelioma Condition: Mesothelioma Date: 2017-03-02 Interventions:
|
Recruiting |
Study Name: Velcade and Eloxatin for Patients With Malignant Pleural or Peritoneal Mesothelioma Condition: Mesothelioma Date: 2009-10-14 Interventions: Drug: Velcade (bortezomib) plus Eloxatin (oxaliplatin) One cycle is defined as an interval of 28 days. A |
Completed |
Study Name: Pemetrexed Plus Gemcitabine or Carboplatin for Patients With Advanced Malignant Pleural Mesothelioma Condition: Mesothelioma Date: 2005-01-07 Interventions:
|